1. Home
  2. LWLG vs SLDB Comparison

LWLG vs SLDB Comparison

Compare LWLG & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$12.37

Market Cap

578.6M

Sector

Industrials

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$7.54

Market Cap

498.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWLG
SLDB
Founded
1991
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.6M
498.6M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
LWLG
SLDB
Price
$12.37
$7.54
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$16.36
AVG Volume (30 Days)
8.1M
971.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
34.97
EPS
N/A
N/A
Revenue
$236,855.00
$8,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
147.74
N/A
52 Week Low
$0.86
$2.52
52 Week High
$15.29
$8.87

Technical Indicators

Market Signals
Indicator
LWLG
SLDB
Relative Strength Index (RSI) 60.15 46.24
Support Level $3.19 $5.16
Resistance Level N/A $7.96
Average True Range (ATR) 1.67 0.47
MACD 0.03 -0.09
Stochastic Oscillator 59.90 2.85

Price Performance

Historical Comparison
LWLG
SLDB

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: